P02: PROGNOSTIC STRATIFICATION OF STANDARD RISK MULTIPLE MYELOMA DEFINED BY REVISED ISS

Autor: G Barilà, L Bonaldi, A Martines, A Pascarella, S Vedovato, C Clissa, N Macrì, A Bonalumi, L Pavan, M Tinelli, S Nalio, A Teramo, G Calabretto, VR Gasparini, M Krampera, R Bassan, R Zambello

Publikováno v: HemaSphere, Vol 6, Pp 11-12 (2022)

Externí odkaz: https://doaj.org/article/aed0a58b618c4f0686ce29db40e3862c

Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia.

Autor: Vicenzetto C; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova., Gasparini VR; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova., Barila G; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova., Teramo A; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova., Calabretto G; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova., Rampazzo E; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova., Carraro S; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova., Trimarco V; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova., Trentin L; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova., Facco M; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova., Semenzato G; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova., Zambello R; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy; Veneto Institute of Molecular Medicine (VIMM), Padova. r.zambello@unipd.it.

Publikováno v: Haematologica [Haematologica] 2024 Jan 01; Vol. 109 (1), pp. 163-174. Date of Electronic Publication: 2024 Jan 01.

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients.

Autor: Barilà G; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy., Grassi A; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy., Cheon H; Department of Medicine and University of Virginia Cancer Center, Division of Hematology & Oncology, University of Virginia School of Medicine, Charlottesville, VA., Teramo A; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy., Calabretto G; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy., Chahal J; Department of Medicine and University of Virginia Cancer Center, Division of Hematology & Oncology, University of Virginia School of Medicine, Charlottesville, VA., Vicenzetto C; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy., Almeida J; Department of Medicine and Cytometry Service, Cancer Research Center (Institute of Molecular and Cell Biology of Cancer-Consejo Superior de Investigaciones Científicas/Universidad de Salamanca), University of Salamanca, Instituto de Investigación Biomédica de Salamanca and Centro de Investigación Biomédica en Red en Oncología, Salamanca, Spain., Shemo BC; Department of Medicine and University of Virginia Cancer Center, Division of Hematology & Oncology, University of Virginia School of Medicine, Charlottesville, VA., Shi M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, NY., Gasparini VR; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy., Munoz-Garcia N; Department of Medicine and Cytometry Service, Cancer Research Center (Institute of Molecular and Cell Biology of Cancer-Consejo Superior de Investigaciones Científicas/Universidad de Salamanca), University of Salamanca, Instituto de Investigación Biomédica de Salamanca and Centro de Investigación Biomédica en Red en Oncología, Salamanca, Spain., Pastoret C; Department of Hematology, Rennes University Hospital, Rennes, France., Nakazawa H; Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan., Oshimi K; Department of Medicine, Division of Hematology, Kushiro Rosai Hospital, Kushiro, Japan., Sokol L; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Ishida F; Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan., Lamy T; Department of Hematology, Rennes University Hospital, Rennes, France., Orfao A; Department of Medicine and Cytometry Service, Cancer Research Center (Institute of Molecular and Cell Biology of Cancer-Consejo Superior de Investigaciones Científicas/Universidad de Salamanca), University of Salamanca, Instituto de Investigación Biomédica de Salamanca and Centro de Investigación Biomédica en Red en Oncología, Salamanca, Spain., Morice WG; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, NY., Loughran TP; Department of Medicine and University of Virginia Cancer Center, Division of Hematology & Oncology, University of Virginia School of Medicine, Charlottesville, VA., Semenzato G; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy., Zambello R; Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine, Padua, Italy.

Publikováno v: Blood [Blood] 2023 Mar 02; Vol. 141 (9), pp. 1036-1046.

Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience.

Autor: Calabretto G; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine (VIMM), Padua, Italy., Attardi E; MDS Unit, Division of Hematology, AOU Careggi-University of Florence, Florence, Italy.; Italian MDS Foundation (FISIM - ETS), Bologna, Italy., Teramo A; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine (VIMM), Padua, Italy., Trimarco V; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy., Carraro S; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy., Mossuto S; Italian MDS Foundation (FISIM - ETS), Bologna, Italy., Barilà G; Hematology Unit, Ospedale dell'Angelo, Venezia-Mestre, Italy., Vicenzetto C; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine (VIMM), Padua, Italy., Gasparini VR; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine (VIMM), Padua, Italy., Crugnola M; Italian MDS Foundation (FISIM - ETS), Bologna, Italy.; Hematology Unit and BMT Center, AOU-Parma, Parma, Italy., Niscola P; Italian MDS Foundation (FISIM - ETS), Bologna, Italy.; Department of Hematology, S. Eugenio Hospital, Rome, Italy., Poloni A; Italian MDS Foundation (FISIM - ETS), Bologna, Italy.; Division of Hematology, AOU Ospedali Riuniti - Università Politecnica Marche, Ancona, Italy., Giai V; Italian MDS Foundation (FISIM - ETS), Bologna, Italy.; Division of Hematology, Department of Oncology, AOU Città della Salute e della Scienza, Turin, Italy., Gaidano V; Italian MDS Foundation (FISIM - ETS), Bologna, Italy.; Department of Hematology, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Finelli C; Italian MDS Foundation (FISIM - ETS), Bologna, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Bertorelle R; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Candiotto C; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Pizzi M; Department of Medicine, Surgical Pathology and Cytopathology Unit, University School of Medicine, Padua, Italy., Binotto G; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy.; MDS Unit, Division of Hematology, AOU Careggi-University of Florence, Florence, Italy., Facco M; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine (VIMM), Padua, Italy., Vianello F; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy., Trentin L; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy., Semenzato G; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy.; Veneto Institute of Molecular Medicine (VIMM), Padua, Italy., Zambello R; Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy. r.zambello@unipd.it.; Veneto Institute of Molecular Medicine (VIMM), Padua, Italy. r.zambello@unipd.it.; Italian MDS Foundation (FISIM - ETS), Bologna, Italy. r.zambello@unipd.it., Santini V; MDS Unit, Division of Hematology, AOU Careggi-University of Florence, Florence, Italy. valeria.santini@unifi.it.; Italian MDS Foundation (FISIM - ETS), Bologna, Italy. valeria.santini@unifi.it.

Publikováno v: Leukemia [Leukemia] 2022 Jul; Vol. 36 (7), pp. 1947-1950. Date of Electronic Publication: 2022 May 21.

Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia.

Autor: Bhattacharya D; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland., Teramo A; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova and Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Gasparini VR; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova and Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Huuhtanen J; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Department of Computer Science, Aalto University, Espoo, Finland., Kim D; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland., Theodoropoulos J; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Department of Computer Science, Aalto University, Espoo, Finland., Schiavoni G; Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, Perugia, Italy., Barilà G; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova and Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Vicenzetto C; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova and Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Calabretto G; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova and Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Facco M; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova and Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Kawakami T; Department of Internal Medicine, Division of Hematology, Shinshu University School of Medicine, Matsumoto, Japan., Nakazawa H; Department of Internal Medicine, Division of Hematology, Shinshu University School of Medicine, Matsumoto, Japan., Falini B; Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, Perugia, Italy., Tiacci E; Institute of Hematology and Center for Hemato-Oncology Research, University and Hospital of Perugia, Perugia, Italy., Ishida F; Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan., Semenzato G; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova and Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Kelkka T; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland., Zambello R; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova and Veneto Institute of Molecular Medicine (VIMM), Padova, Italy., Mustjoki S; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. satu.mustjoki@helsinki.fi.; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland. satu.mustjoki@helsinki.fi.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. satu.mustjoki@helsinki.fi.

Publikováno v: Blood cancer journal [Blood Cancer J] 2022 Feb 24; Vol. 12 (2), pp. 31. Date of Electronic Publication: 2022 Feb 24.